ARTL stock

Artelo Biosciences Inc (ARTL) financials · $15.6M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Artelo Biosciences Inc (ARTL) $15.6M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$11.4M-$10.1M
Net Income-$12.9M-$9.83M
EPS (Diluted)-$12.52-$3.05
Cached annual balance sheet
LineFY2025FY2024
Total Assets$2.80M$4.70M
Current Assets$695.0K$2.56M
Cash & Equivalents$600.0KN/A
Total Liabilities$4.07M$1.84M
Current Liabilities$4.04M$1.77M
Shareholders' Equity-$1.27M$2.86M
Retained Earnings-$63.0M-$50.1M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$8.52M-$8.35M
Investing Cash Flow-$62.0K$7.77M
Financing Cash Flow$6.87M$112.0K
Net Change in Cash-$1.74M-$477.0K
These statements as JSON? API free 100/day

FAQ

What is ARTL P/E and revenue?

Artelo Biosciences Inc (ARTL) $15.6M cap.

What is ARTL revenue?

ARTL income-statement cache has no revenue figure yet.

Is ARTL profitable?

Artelo Biosciences Inc last cached net income is -$12.9M (FY2025).

What are ARTL total assets?

Artelo Biosciences Inc last cached total assets are $2.80M (FY2025).

What is ARTL free cash flow?

No cached cash-flow row for ARTL yet.

Not investment advice. Cached statements, not a live tape.